Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Notice Of The National Company Law Tribunal Convened Meetings Of The Equity Shareholders And Unsecured Creditors Of Sun Pharmaceutical Industries Limited

 Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the copies of the Notices of the NCLT Convened Meetings of the equity shareholders and unsecured creditors of the Company dated April 26, 2017, as directed by Hon'ble NCLT, Ahmedabad Bench, vide its order dated April 18, 2017, convening Meetings on Tuesday, June 20, 2017 at 10:15 a.m....
11-05-2017
Bigul

Board to consider FY17 Results & Dividend on May 26, 2017

 Sun Pharmaceutical Industries Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 26, 2017, inter alia, to transact the following business:1. To consider and approve standalone and consolidated Audited Financial Results of the Company for the quarter and year ended March 31, 2017.2. To consider recommendation of dividend for the year ended March 31, 2017 subject to the approval of the shareholders...
11-05-2017
Bigul

Board Meeting On 26/05/2017

 Dear Sirs, This is to inform you that a meeting of the Board of Directors of the Company will be held on Friday, May 26, 2017, interalia, to transact the following business : (i)To consider and approve standalone and consolidated Audited Financial Results of the Company for the quarter and year ended March 31, 2017. (ii)To consider recommendation of dividend for the year ended March 31, 2017 subject to the approval of the shareholders at...
11-05-2017
Bigul

Disclosures under Reg. 10(7) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(ii) & (iii)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shanghvi Finance Pvt Ltd
06-05-2017
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pratham Investments
03-05-2017
Bigul

Press Release

 Dear Sirs, We are pleased to enclose herewith our Press Release relating to recognizes Indian scientists & young research scholars by Sun Pharma Science Foundation, which we shall be releasing after sending this letter to you. This is for your information and records. Thanking you,
28-04-2017
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Raksha Sudhir Valia (PAC)
26-04-2017
Bigul

FDEC commences roll-out of Malaria demonstration project

 Sun Pharmaceutical Industries Ltd has informed BSE regarding a Press Release dated April 25, 2017 titled "FDEC commences roll-out of Malaria demonstration project".
25-04-2017
Bigul

Compliance Certificate - Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 As per the requirements of Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find herewith the Compliance Certificate dated 24 April, 2017 issued by Mr. Chintan Goswami, M/S. C. J Goswami & Associates, Practicing Company Secretaries, for the half year ended 31st March, 2017
24-04-2017
Bigul

Consider a bull spread on Sun Pharma

 Sun Pharmaceutical Industries (639.6) is ruling at a crucial level. The stock finds support at 610 and the crucial one at 572. A close below the latter will confirm the bearish trend. Only a...
23-04-2017
Next Page
Close

Let's Open Free Demat Account